Researcher
Samir Kumar-Singh
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Infectious diseases, Anatomical pathology, Neurological and neuromuscular diseases, Clinical genetics and molecular diagnostics
Affiliations
- Laboratory of Medical Microbiology (LMM) (Research group)
Member
From1 Jan 2019 → Today - Laboratory of cell biology and histology (Research group)
Member
From1 Oct 2011 → Today - Translational Neurosciences (TNW) (Research group)
Member
From1 Oct 2011 → Today - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2011 → 31 Dec 2018 - Department of Biomedical Sciences - other (Research group)
Member
From1 Mar 2010 → 30 Sep 2011 - VIB CMN - Neurodegenerative Brain Diseases Group (Research group)
Member
From1 Oct 2003 → 28 Feb 2010
Projects
1 - 10 of 30
- Fecal microbiotal transplantation as a method for improving the outcomes of the dual radio- and immunotherapies within a colorectal cancer mouse model.From1 Oct 2022 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Advanced Centre for Advanced Microscopy (ACAM).From1 Jan 2022 → TodayFunding: BOF - research organisations
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Molecular insights in SARS-CoV-2 pathogenesis and epidemiology.From1 Jun 2020 → 31 May 2021Funding: BOF - projects
- High-resolution slide scanner for digital histopathological phenotyping in health and disease.From1 Jan 2020 → 31 Dec 2021Funding: BOF - scientific equipment program
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- The impact of mixed or polymicrobial flora in the development of ventilator-associated pneumonia.From1 Oct 2019 → 31 May 2022Funding: BOF - doctoral mandates
- The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use (VALUE-Dx).From1 Apr 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing, Foreign industrial entreprises
Publications
1 - 10 of 82
- Cytokine expression in cancer survivors suffering from chronic pain(2024)
Authors: Amber De Groote, Thijs Vande Vyvere, Wiebren Tjalma, Wim Vanden Berghe, Samir Kumar-Singh, An De Groef, Mira Meeus
Pages: E207 - E220 - Immunological biomarkers of COVID-19(2023)
Authors: Angelina Konnova, Samir Kumar-Singh, Surbhi Malhotra, An Hotterbeekx, Matilda Berkell
Number of pages: 193 - Clinical phenotypes and quality of life to define post-COVID-19 syndrome(2023)
Authors: Elisa Gentilotti, Anna Gorska, Adriana Tami, Roy Gusinow, Massimo Mirandola, Jesus Rodriguez Bano, Zaira R. Palacios Baena, Elisa Rossi, Jan Hasenauer, Iris Lopes-Rafegas, et al.
Pages: 1 - 11 - High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients(2023)
Authors: Houssem Redha Chenane, Guillaume Lingas, Reyene Menidjel, Cedric Laouenan, Sarah Tubiana, Diane Descamps, Quentin Le Hingrat, Laurent Abel, Jeremie Guedj, Surbhi Malhotra, et al.
Pages: 1 - 6 - Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments(2023)
Authors: Akshita Gupta, Angelina Konnova, Matilda Berkell, Alessia Savoldi, Matteo Morra, Vincent Van Averbeke, Fien De Winter, Denise Peserico, Elisa Danese, An Hotterbeekx, et al.
Pages: 1 - 14 - Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273(2023)
Authors: Julia M. Neuhann, Jannik Stemler, Antonio J. Carcas, Jesús Frías-Iniesta, Murat Akova, Ullrich Bethe, Sarah Heringer, Jon Salmanton-García, Lea Tischmann, Marouan Zarrouk, et al.
Pages: 7166 - 7175 - Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients(2023)
Authors: Maddalena Giannella, Manuel Huth, Elda Righi, Jan Hasenauer, Lorenzo Marconi, Angelina Konnova, Akshita Gupta, An Hotterbeekx, Matilda Berkell, Zaira R. Palacios-Baena, et al.
Pages: 1084e1 - 1084e7 - Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer(2023)
Authors: Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara Ahmed, Natalie Leys, Samir Kumar-Singh, Surbhi Malhotra, Rob Van Houdt
Pages: 1 - 24 - Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis(2022)
Authors: Karen Claesen, Yani Sim, An Bracke, Michelle De bruyn, Emilie De Hert, Gwendolyn Vliegen, An Hotterbeekx, Alexandra Vujkovic, Lida van Petersen, Fien De Winter, et al.
Pages: 1 - 11 - Subtle vascular and astrocytic changes in the brain of coronavirus disease 2019 (COVID‐19) patients(2022)
Authors: Gabriela Camelia Rosu, Valentin Octavian Mateescu, Alexandra Simionescu, Anca‐Maria Istrate‐Ofiteru, George Cristian Curcă, Ionica Pirici, Laurentiu Mogoanta, Ion Mindrila, Samir Kumar-Singh, Sorin Hostiuc, et al.
Pages: 3676 - 3692
Patents
1 - 5 of 5
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)